Christopher J. Molineaux
Corporate Officer/Principal at CALITHERA BIOSCIENCES, INC.
Profile
Dr. Christopher J.
Molineaux is a Senior Vice President-Development at Calithera Biosciences, Inc. Dr. Molineaux was previously employed as a President by Indstrat LLC, a Vice President-Development by Proteolix, Inc., a Senior Director-Drug Development by FibroGen, Inc., a Research Manager-Toxicology by J&J Pharmacy, a Senior Director-Pharmacology by Praecis Pharmaceuticals, Inc., an Assistant Professor by Mount Sinai School of Medicine, a Chief Development Officer by BerGenBio ASA, a Principal by Enzon Pharmaceuticals, Inc., and a Principal by Merck & Co., Inc. He received his undergraduate degree from the University of Maryland and a doctorate degree from The Johns Hopkins University.
Christopher J. Molineaux active positions
| Companies | Position | Start |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Corporate Officer/Principal | 2013-03-31 |
Former positions of Christopher J. Molineaux
| Companies | Position | End |
|---|---|---|
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Chief Tech/Sci/R&D Officer | 2009-06-25 |
| Indstrat LLC | President | 2012-12-31 |
| FIBROGEN, INC. | Corporate Officer/Principal | 2003-12-31 |
| J&J Pharmacy | Corporate Officer/Principal | 1999-12-31 |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 1998-12-31 |
Training of Christopher J. Molineaux
| The Johns Hopkins University | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| BERGENBIO ASA | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
| J&J Pharmacy | |
| Indstrat LLC |
- Stock Market
- Insiders
- Christopher J. Molineaux
